Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-19T23:08:09.187Z Has data issue: false hasContentIssue false
  • English
  • Français

Olanzapine cotherapy in prevention of recurrence in bipolar disorder

Published online by Cambridge University Press:  16 April 2020

M. Tohen ,
K.N.R. Chengappa ,
T. Suppes ,
R.W. Baker ,
R.C. Risser ,
A.R. Evans  and
J.R. Calaberse
M. Tohen
Affiliation:
Lilly Research Laboratories
K.N.R. Chengappa
Affiliation:
Western Psychiatric Institute & Clinic, University of Pittsburgh Medical Center
T. Suppes
Affiliation:
Department of Psychiatry, University of Texas Southwestern Medical Center
R.W. Baker
Affiliation:
Lilly Research Laboratories
R.C. Risser
Affiliation:
Lilly Research Laboratories
A.R. Evans
Affiliation:
Lilly Research Laboratories
J.R. Calaberse
Affiliation:
Department of Psychiatry, Case Western Reserve, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Sunday, 5 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 109s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.